Annals of Emergency Medicine
Volume 52, Issue 2 , Pages S27-S39 , August 2008

Transient Ischemic Attack: Risk Stratification and Treatment

  • Brett Cucchiara, MD

      Affiliations

    • Department of Neurology, University of Pennsylvania, Philadelphia, PA
    • Corresponding Author InformationAddress for correspondence: Brett Cucchiara, MD, Department of Neurology, University of Pennsylvania Medical Center, 3 West Gates Building, 3400 Spruce Street, Philadelphia, PA 19104
    • ,
  • Michael Ross, MD

      Affiliations

    • Department of Emergency Medicine, Emory University, Atlanta, GA.

References 

  1. Johnston SC, Gress DR, Browner WS, et al. Short-term prognosis after emergency department diagnosis of transient ischemic attack. JAMA. 2000;284:2901–2906
  2. Rothwell PM, Giles MF, Flossmann E, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005;366:29–36
  3. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369:283–292
  4. Tsivgoulis G, Spengos K, Manta P, et al. Validation of the ABCD score in identifying individuals at high early risk of stroke after a transient ischemic attack: a hospital-based case series study. Stroke. 2006;37:2892–2897
  5. Tsivgoulis G, Vassilopoulou S, Spengos K. Potential applicability of ABCD score in triaging transient ischemic attack patients. Lancet. 2007;369:1082
  6. Bray JE, Coughlan K, Bladin C. Can the ABCD score be dichotomised to identify high-risk patients with transient ischaemic attack in the emergency department?. Emerg Med J. 2007;24:92–95
  7. Purroy F, Molina CA, Montaner J, et al. Absence of usefulness of ABCD score in the early risk of stroke of transient ischemic attack patients. Stroke. 2007;38:855–856author reply 857
  8. Cucchiara BL, Messe SR, Taylor RA, et al. Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack?. Stroke. 2006;37:1710–1714
  9. Redgrave JN, Coutts SB, Schulz UG, et al. Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke. 2007;38:1482–1488
  10. Purroy F, Montaner J, Rovira A, et al. Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke. 2004;35:2313–2319
  11. Coutts SB, Simon JE, Eliasziw M, et al. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol. 2005;57:848–854
  12. Boulanger JM, Coutts SB, Eliasziw M, et al. Diffusion-weighted imaging-negative patients with transient ischemic attack are at risk of recurrent transient events. Stroke. 2007;38:2367–2369
  13. Redgrave JN, Schulz UG, Briley D, et al. Presence of acute ischaemic lesions on diffusion-weighted imaging is associated with clinical predictors of early risk of stroke after transient ischaemic attack. Cerebrovasc Dis. 2007;24:86–90
  14. Calvet D, Lamy C, Touze E, et al. Management and outcome of patients with transient ischemic attack admitted to a stroke unit. Cerebrovasc Dis. 2007;24:80–85
  15. Eliasziw M, Kennedy J, Hill MD, et al. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ. 2004;170:1105–1109
  16. Nguyen-Huynh MN, Johnston SC. Is hospitalization after transient ischemic attack cost-effective on the basis of treatment with TPA?. Neurology. 2005;65:1799–1801
  17. Poisson SN, Lisabeth LD, Brown DL, et al. Effect of hospital admission on stroke risk following transient ischemic attack. Neurology. 2007;68(suppl 1):A193
  18. Johnston SC, Nguyen-Huynh MN, Schwarz ME, et al. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol. 2006;60:301–313
  19. Rothwell PM, Giles MF, Chandratheva A, et al. Early Use of Existing Strategies for Stroke (EXPRESS) Study (Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison). Lancet. 2007;370:1432–1442
  20. Lavallée PC, Mesequer E, Abboud H, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-transient ischemic attack): feasibility and effects. Lancet Neurol. 2007;6:953–960
  21. Goldstein LB, Bian J, Samsa GP, et al. New transient ischemic attack and stroke: outpatient management by primary care physicians. Arch Intern Med. 2000;160:2941–2946
  22. Mace SE, Graff L, Mikhail M, et al. A national survey of observation units in the United States. Am J Emerg Med. 2003;21:529–533
  23. Roberts RR, Zalenski RJ, Mensah EK, et al. Costs of an emergency department-based accelerated diagnostic protocol versus hospitalization in patients with chest pain: a randomized controlled trial. JAMA. 1997;278:1670–1676
  24. Gomez MA, Anderson JL, Karagounis LA, et al. An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). J Am Coll Cardiol. 1996;28:25–33
  25. Ross MA, Compton S, Medado P, et al. An emergency department diagnostic protocol for patients with transient ischemic attack: a randomized controlled trial. Ann Emerg Med. 2007;50:109–119
  26. Krol AL, Coutts SB, Simon JE, et al. VSG Perfusion MRI abnormalities in speech or motor transient ischemic attack patients. Stroke. 2005;36:2487–2489
  27. Wojner-Alexander AW, Garami Z, Chernyshev OY, et al. Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology. 2005;64:1354–1357
  28. Ahmed N, Wahlgren NG. Effects of blood pressure lowering in the acute phase of total anterior circulation infarcts and other stroke subtypes. Cerebrovasc Dis. 2003;15:235–243
  29. Oliveira-Filho J, Silva SC, Trabuco CC, et al. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology. 2003;61:1047–1051
  30. Sherman DG, Albers GW, Bladin C, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL study): an open-label randomised comparison. Lancet. 2007;369:1347–1355
  31. Johnston SC, Leira EC, Hansen MD, et al. Early recovery after cerebral ischemia risk of subsequent neurological deterioration. Ann Neurol. 2003;54:439–444
  32. Wiebers DO, Whisnant JP, O'Fallon WM. Reversible ischemic neurologic deficit (RIND) in a community: Rochester, Minnesota, 1955-1974. Neurology. 1982;32:459–465
  33. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997;349:1569–1581
  34. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet. 1997;349:1641–1649
  35. Multicentre Acute Stroke Trial–Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke. Lancet. 1995;346:1509–1514
  36. Chen ZM, Sandercock P, Pan HC, et al. CAST and IST Collaborative Groups Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke. 2000;31:1240–1249
  37. Anonymous. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2:349–360
  38. Kennedy J, Hill MD, Ryckborst KJ, et al. Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER): a randomized controlled pilot trial. Lancet Neurol. 2007;6:961–969
  39. Biller J, Bruno A, Adams HP, et al. A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks (A pilot study). Stroke. 1989;20:441–447
  40. Putnam SF, Adams HP. Usefulness of heparin in initial management of patients with recent transient ischemic attacks. Arch Neurol. 1985;42:960–962
  41. Keith DS, Phillips SJ, Whisnant JP, et al. Heparin therapy for recent transient focal cerebral ischemia. Mayo Clin Proc. 1987;62:1101–1106
  42. Berge E, Sandercock P. Anticoagulants versus antiplatelet agents for acute ischaemic stroke. Cochrane Database Syst Rev. 2002;(4):CD003242.
  43. Wong KS, Chen C, Ng PW, et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol. 2007;6:407–413
  44. Adams HP, Bendixen BH, Leira E, et al. Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999;53:122–125
  45. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004;363:915–924
  46. Alamowitch S, Eliasziw M, Algra A, et al. Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet. 2001;357:1154–1160
  47. Lyrer P, Engelter S. Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst Rev. 2003;(3):CD000255.
  48. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–867
  49. Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged study, BAFTA): a randomised controlled trial. Lancet. 2007;370:493–503
  50. Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903–1912
  51. Berge E, Abdelnoor M, Nakstad PH, et al. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet. 2000;355:1205–1210
  52. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86
  53. Serebruany VL, Steinhubl SR, Berger PB, et al. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Am J Cardiol. 2005;95:1218–1222
  54. Patrono C, Garcia Rodriguez LA, Landolfi R, et al. Low dose aspirin for the prevention of atherothrombosis. N Engl J Med. 2005;353:2373–2383
  55. CAPRIE Steering Committee. A randomised, blinded, trial of Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE). Lancet. 1996;348:1329–1339
  56. Hass WK, Easton JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med. 1989;321:501–507
  57. Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet. 1989;1:1215–1220
  58. Gorelick PB, Richardson D, Kelly M, et al. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA. 2003;289:2947–2957
  59. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study 2 (Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke). J Neurol Sci. 1996;143:1–13
  60. Halkes PH, van Gijn J, Kappelle LJ, et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367:1665–1673
  61. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331–337
  62. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706–1717
  63. Diener HC, Sacco R, Yusuf S Steering Committee and PRoFESS Study Group. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovasc Dis. 2007;23:368–380
  64. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577–617
  65. Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:483S–512S
  66. Collins R, Armitage J, Parish S, et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363:757–767
  67. Amarenco P, Bogousslavsky J, Callahan A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549–559
  68. Briel M, Schwartz GG, Thompson PL, et al. Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials. JAMA. 2006;295:2046–2056
  69. Aronow HD, Novaro GM, Lauer MS, et al. In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis. Arch Intern Med. 2003;163:2576–2582
  70. Cucchiara B, Kasner SE. Use of statins in CNS disorders. J Neurol Sci. 2001;187:81–89
  71. Goldstein LB SPARCL Investigators. The SPARCL trial: effect of statins on stroke severity. Ann Neurol. 2006;60(suppl 10):S85
  72. Progress Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–1041
  73. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115:e478–e534
  74. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655–1711
  75. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768–774

 Supervising editor: Allan B. Wolfson, MD

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that might create any potential conflict of interest. BC has received honoraria for lectures from Boehringer Ingelheim and Bristol-Myers Squibb/Sanofi. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement.This article was part of a supplement sponsored by Boehringer Ingleheim Pharmaceuticals, Inc.

PII: S0196-0644(08)00834-2

doi: 10.1016/j.annemergmed.2008.05.019

Annals of Emergency Medicine
Volume 52, Issue 2 , Pages S27-S39 , August 2008

Article Tools

* Image Usage & Resolution